In our data analysis, we found that group IV* (CD8AhighIDO1high*) using the secondary IDO1 peak (the higher cut-off for IDO1 expression) had the worst prognosis among the four subgroups of colon cancer. The gene discussed is IDO1; the disease is malignant colon neoplasm.